- Home
- NKTX vs NNBR Comparison
NKTX vs NNBR Comparison
Compare NKTX & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- NNBR
- Stock Information
- Founded
- NKTX 2015
- NNBR 1980
- Country
- NKTX United States
- NNBR United States
- Employees
- NKTX N/A
- NNBR N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- NNBR Industrial Machinery/Components
- Sector
- NKTX Health Care
- NNBR Industrials
- Exchange
- NKTX Nasdaq
- NNBR Nasdaq
- Market Cap
- NKTX 123.5M
- NNBR 108.0M
- IPO Year
- NKTX 2020
- NNBR 1994
- Fundamental
- Price
- NKTX $2.37
- NNBR $2.40
- Analyst Decision
- NKTX Strong Buy
- NNBR
- Analyst Count
- NKTX 5
- NNBR 0
- Target Price
- NKTX $13.50
- NNBR N/A
- AVG Volume (30 Days)
- NKTX 556.1K
- NNBR 120.3K
- Earning Date
- NKTX 08-12-2025
- NNBR 08-06-2025
- Dividend Yield
- NKTX N/A
- NNBR N/A
- EPS Growth
- NKTX N/A
- NNBR N/A
- EPS
- NKTX N/A
- NNBR N/A
- Revenue
- NKTX N/A
- NNBR $433,709,000.00
- Revenue This Year
- NKTX N/A
- NNBR N/A
- Revenue Next Year
- NKTX N/A
- NNBR $4.96
- P/E Ratio
- NKTX N/A
- NNBR N/A
- Revenue Growth
- NKTX N/A
- NNBR N/A
- 52 Week Low
- NKTX $1.31
- NNBR $1.58
- 52 Week High
- NKTX $6.63
- NNBR $4.67
- Technical
- Relative Strength Index (RSI)
- NKTX 64.66
- NNBR 61.22
- Support Level
- NKTX $2.23
- NNBR $2.24
- Resistance Level
- NKTX $2.50
- NNBR $2.39
- Average True Range (ATR)
- NKTX 0.13
- NNBR 0.12
- MACD
- NKTX 0.02
- NNBR 0.01
- Stochastic Oscillator
- NKTX 76.85
- NNBR 80.49
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.